Next Article in Journal
Biodegradable Polymers and Stem Cells for Bioprinting
Next Article in Special Issue
Red Light Activation of Ru(II) Polypyridyl Prodrugs via Triplet-Triplet Annihilation Upconversion: Feasibility in Air and through Meat
Previous Article in Journal
The Traditional Medicine and Modern Medicine from Natural Products
Previous Article in Special Issue
Cellular Uptake and Photo-Cytotoxicity of a Gadolinium(III)-DOTA-Naphthalimide Complex “Clicked” to a Lipidated Tat Peptide
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessArticle
Molecules 2016, 21(5), 570; doi:10.3390/molecules21050570

Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors

Institute of Pharmacy, University of Kiel, Gutenbergstr. 76, D-24118 Kiel, Germany
*
Author to whom correspondence should be addressed.
Academic Editor: Wiktor Szymański
Received: 16 March 2016 / Revised: 20 April 2016 / Accepted: 21 April 2016 / Published: 29 April 2016
(This article belongs to the Special Issue Photoresponsive Drugs)
View Full-Text   |   Download PDF [3580 KB, uploaded 29 April 2016]   |  

Abstract

In this study, we report on the design, synthesis, photokinetic properties and in vitro evaluation of photoactivatable caged prodrugs for the receptor tyrosine kinase VEGFR-2. Highly potent VEGFR-2 inhibitors 1 and 3 were caged by introduction of a photoremovable protecting group (PPG) to yield the caged prodrugs 4 and 5. As expected, enzymatic and cellular proliferation assays showed dramatically diminished efficacy of caged prodrugs in vitro. Upon ultraviolet (UV) irradiation of the prodrugs original inhibitory activity was completely restored and even distinctly reinforced, as was the case for the prodrug 4. The presented results are a further evidence for caging technique being an interesting approach in the protein kinase field. It could enable spatial and temporal control for the inhibition of VEGFR-2. The described photoactivatable prodrugs might be highly useful as biological probes for studying the VEGFR-2 signal transduction. View Full-Text
Keywords: photoactivatable prodrugs; caging; receptor tyrosine kinase; kinase inhibitors; VEGFR-2; 3,4-diarylmaleimides; photoremovable protecting group (PPG) photoactivatable prodrugs; caging; receptor tyrosine kinase; kinase inhibitors; VEGFR-2; 3,4-diarylmaleimides; photoremovable protecting group (PPG)
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Pinchuk, B.; Horbert, R.; Döbber, A.; Kuhl, L.; Peifer, C. Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors. Molecules 2016, 21, 570.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top